Advertisement

Topics

Recombinant Zoster Vaccine Reduces Shingles Risk After Stem Cell Transplantation

15:27 EDT 9 Jul 2019 | NEJM

The adjuvanted recombinant herpes zoster vaccine helps prevent zoster in patients who've recently undergone autologous stem cell transplantation — a group known to be at high...

Original Article: Recombinant Zoster Vaccine Reduces Shingles Risk After Stem Cell Transplantation

NEXT ARTICLE

More From BioPortfolio on "Recombinant Zoster Vaccine Reduces Shingles Risk After Stem Cell Transplantation"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Recombinant DNA
Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology. The procedure is to cut the DNA of ...

Vaccine
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...